4Chen G Q,Zhu J,Shi X G,et al.In vitro studies on cellular and molecular mechanismsof arsenic trioxide(As2O3)in the treatment of acute promyelocyticleukemia:As2O3 induces NB4 cell apoptosis with downregulation ofBcl-2 expression and modulation of PML-RAR alpha/PML proteins.Blood,1996，88:1052～1061
5Chen G Q,Shi X G,Tang W,et al.Use of arsenic Trioxide(As2O3)in the treatment of acute prom-yelocytic leukemia(APL):I.As2O3Exerts Dose-Dependent Dual Effects on APL cells.Blood,1997，89:3345～3353
6Gianni M,Koken M H M, Chelbi-Alix M K,et al.Combined arsenic and retinoic acidtreatment enhances differentiation and apoptosis in arsenic-resistant NB4cells.Blood,1998,91:4300～4310
7Bazarbachi A, el-Sabban M E, Nasr R,et al. Arsenic Trioxide and Interferon-αsynergize to induce cell cycle arrest and apoptosis in human T-cell Lymphotropic virustype-I transformed cells. Blood,1999,93:278～283
8Dai J, Weinberg R, Waxman S,et al.Maligant cells can be sensitized to undergogrowth inhibition and apoptosis by arsenic trioxide through modulation of the glutathioneredox system .Blood,1999,93:268～277
9K?nigA,Wrazel L,Warrell-J R Rp,et al.Comparative activity of melarsoprol and arsenic trioxidein chronic B-cell leukemia lines.Blood,1997,90:562～570
10Wang Z G,Rivi R,Delva L,et al.Arsenic trioxide and melarsoprol induce programmedcell death in myeloid leukemia cell lines and function in a PML and PML-RAR α independentManner.Blood,1998,92:1497～1504
